Harvesting the biosynthetic machineries that cultivate a variety of indispensable plant natural products.

“Plants are a sustainable resource for valuable natural chemicals best illustrated by large-scale farming centered on specific products. Here, we review recent discoveries of plant metabolic pathways producing natural products with unconventional biomolecular structures.

Prenylation of polyketides by aromatic prenyltransferases (aPTases) ties together two of the major groups of plant specialized chemicals, terpenoids and polyketides, providing a core modification leading to new bioactivities and downstream metabolic processing. Moreover, PTases that biosynthesize Z-terpenoid precursors for small molecules such as lycosantalene have recently been found in the tomato family.

Gaps in our understanding of how economically important compounds such as cannabinoids are produced are being identified using next-generation ‘omics’ to rapidly advance biochemical breakthroughs at an unprecedented rate. For instance, olivetolic acid cyclase, a polyketide synthase (PKS) co-factor from Cannabis sativa, directs the proper cyclization of a polyketide intermediate.

Elucidations of spatial and temporal arrangements of biosynthetic enzymes into metabolons, such as those used to control the efficient production of natural polymers such as rubber and defensive small molecules such as linamarin and lotaustralin, provide blueprints for engineering streamlined production of plant products.”

http://www.ncbi.nlm.nih.gov/pubmed/26851514

Biomedical benefits of cannabinoids?

“Cannabinoids appear to be of therapeutic value as antiemetics, antispasmodics, analgesics and appetite stimulants and may have potential uses in epilepsy, glaucoma and asthma.

This paper reviews the clinical trials which have been carried out with cannabinoids including Δ⁹-tetrahydrocannabinol (THC) and synthetic cannabinoids such as nabilone and levonantradol, and discusses the advantages and adverse effects of cannabinoids in clinical use.

The place of cannabinoids in modern medicine remains to be properly evaluated, but present evidence suggests that they could be valuable, particularly as adjuvants, for symptom control in a range of conditions for which standard drugs are not fully satisfactory.”

Study claims marijuana tied to lower bladder cancer risk – USA TODAY

“A new study compared the risk of bladder cancer in more than 83,000 men who smoked cigarettes only, marijuana only, or both substances. New research says smoking pot may be less likely to cause bladder cancer than smoking cigarettes.”

“The finding is potentially valuable, the study authors said, given the ongoing debate over legalizing marijuana for medical purposes.”

More: http://www.usatoday.com/story/news/nation/2013/05/11/study-claims-marijuana-tied-to-lower-bladder-cancer-risk/2153019/

“Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study.” http://www.ncbi.nlm.nih.gov/pubmed/25623697

http://www.thctotalhealthcare.com/category/bladder-cancer/

Study Claims Marijuana Tied to Lower Bladder Cancer Risk – Health

marijuana Study Claims Marijuana Tied to Lower Bladder Cancer Risk

New research says smoking pot may be less likely to cause bladder cancer than smoking cigarettes.

The finding is potentially valuable, the study authors said, given the ongoing debate over legalizing marijuana for medical purposes.”

More: http://news.health.com/2013/05/10/study-claims-marijuana-tied-to-lower-bladder-cancer-risk/